Are you Dr. Rettig? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileAt a glance
- 200 UCLA Medical Plz Ste 140, Los Angeles, CA 90095
About Dr. Rettig
Matthew Rettig, MD practices hematology & oncology in Los Angeles, CA. Matthew is a 1990 graduate of Duke University School of Medicine. Matthew is also listed as specializing in medical oncology and urology. According to Medicare claims data, Matthew cared for 381 Medicare patients across 1,037 services. The services billed most often include leuprolide acetate (for depot suspension), 7.5 mg, established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more, and established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more. The provider's National Provider Identifier (NPI) is 1487751798.
Factual summary compiled by Guide.md from public records; not written by this provider.
Education & Training
Specialty
Credentials & Licensing
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (310) 794-7152
- Email not available
Practice Locations
200 UCLA MEDICAL PLZ STE 140
Los Angeles, CA 90095
Conditions Commonly Evaluated or Treated
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Advanced Cancers
Blood & Lymph Disorders
Blood Cancers
Blood Disorders
- Bleeding Disorders
- Blood Clot in Lung
- Blood Clotting Gene Mutation
- Deep vein thrombosis
- Hemochromatosis
- High Platelet Count
- High White Blood Cell Count
- Low Platelets
- Low White Blood Cell Count
- Thick Blood
- Unexplained Bruising
Blood disorders
- Bone Marrow Scarring
- Hemolytic Anemia in Children
- Pre-Myeloma Protein In Blood
- Vitamin B12 deficiency anemia
Bone & Soft Tissue Cancers
Digestive Cancers
Endocrine Cancers
Endocrine tumors
Gastrointestinal cancer
General oncology
Genetic Blood Disorders
Gynecologic cancer
Gynecologic Cancers
Head & Neck Cancers
Head and neck cancer
Neurologic Cancers
Oncologic emergencies
Ophthalmologic oncology
Skin cancer
Skin Cancers
Urologic Cancers
Procedures & services
Biopsies & Diagnostics
Cancer care
Pain & wellness
Most searched procedures
Blood disorder care
Cancer Therapies
Cancer therapy
- Chemo allergy desensitization
- Oral chemotherapy management
- Radiation oncology consultation
- Spinal chemo injection
Cellular Therapies
Consultations
Diagnostic testing
Hematology Treatments
Imaging
Infusions
Interventional oncology
Supportive Cancer Care
- Bone Strengthening Injections For Cancer
- Pain Management For Cancer
- Red Blood Cell Booster Shot
- White Blood Cell Booster Injection
Supportive cancer care
- Cancer nutrition counseling
- Chemo brain treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hyperbaric oxygen for radiation damage
- Lymphedema Drainage Therapy
- Palliative cancer care
Surgical & Vascular Access
- Chemo port placement
- Chemo port removal
- Draining lung fluid
- Paracentesis
- PICC line placement coordination
Testing & Genetics
Vascular access care
Procedures Most Often Billed to Medicare
1,037 services · 381 patients · 7 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96402 |
87 | More often than most peers in Hematology & Oncology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
19 | Less often than most peers in Hematology & Oncology |
| Leuprolide acetate (for depot suspension), 7.5 mg | Drug given | J9217 |
379 | More than most peers in Hematology & Oncology |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
324 | As often as other peers in Hematology & Oncology |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | Office visit | 99213 |
152 | More often than most peers in Hematology & Oncology |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | Office visit | 99215 |
46 | Less often than most peers in Hematology & Oncology |
| New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | Office visit | 99205 |
30 | As often as other peers in Hematology & Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Other cancer specialists at this location 1
Same specialty, same street address — most likely the same department or group.
Related specialists at this location 1
Clinically related specialties at the same address — the people this provider most likely works alongside.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
More connections — 32 related providers in 4 groups
Other cancer specialists in Los Angeles 8
Same specialty, same city.
Trained at Duke University School of Medicine 8
Other providers in the same specialty who trained at the same institution.
Class of 1990 at Duke University School of Medicine 8
Providers who graduated from the same medical school in the same year.
Also performs Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle 8
Providers in CA who bill this service to Medicare most often.
Common questions
What is Dr. Rettig's specialty?
Dr. Rettig is a cancer specialist in Los Angeles, CA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
Where can I find Dr. Rettig?
Dr. Rettig is listed at 200 UCLA Medical Plz Ste 140, Los Angeles, CA 90095. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
How do I contact Dr. Rettig?
The number on file is (310) 794-7152. Contact the office directly to confirm availability and scheduling.
NPI registry
What is Dr. Rettig's NPI number?
Dr. Rettig's National Provider Identifier is 1487751798. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
What is Dr. Rettig's medical education?
Dr. Rettig attended Duke University School of Medicine, graduating in 1990. This comes from the CMS National Downloadable File.
CMS public data
How long has Dr. Rettig been practicing?
Dr. Rettig has 36 years experience. Calculated from a graduation year of 1990, reported in the CMS National Downloadable File.
CMS public data
What is Dr. Rettig known for?
According to Medicare billing data, Dr. Rettig provides treatments such as administration of hormonal anti-neoplastic chemotherapy under skin or into muscle and injection of drug or substance under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Has Dr. Rettig confirmed this information?
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Rettig. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.